KAPA

Kairos Pharma Ltd

0.3500

Jun 26 • 04:00PM ET -0.0248 (-6.62%)

Healthcare Biotechnology USA Nano AMEX

Peers: APRE BCDA BIVI CALC CVM GOVX KPRX NEUP AIM JAGX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.30	Insider Own	40.92%	Shs Outstand	21.41M	Perf Week	-18.60%
Market Cap	7.49M	Forward P/E	-	EPS next Y	-0.67	Insider Trans	0.00%	Shs Float	13.45M	Perf Month	-32.33%
Enterprise Value	3.82M	PEG	-	EPS next Q	-0.09	Inst Own	2.81%	Short Float	1.15%	Perf Quarter	-40.50%
Income	-5.84M	P/S	-	EPS this Y	-23.33%	Inst Trans	-7.67%	Short Ratio	1.22	Perf Half Y	-53.46%
Sales	0.00M	P/B	1.41	EPS next Y	-81.08%	ROA	-85.36%	Short Interest	0.15M	Perf YTD	-50.70%
Book/sh	0.25	P/C	2.04	EPS next 5Y	-	ROE	-93.84%	52W High	2.11 -83.41%	Perf Year	-49.28%
Cash/sh	0.17	P/FCF	-	EPS past 3/5Y	-53.52% -29.30%	ROIC	-109.90%	52W Low	0.37 -6.12%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	10.16% 8.06%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-17.50%	Oper. Margin	-	ATR (14)	0.04	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	10.31	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	24.62	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.31	EPS Q/Q	1.01%	SMA20	-20.68%	Beta	1.58	Target Price	12.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-31.49%	Rel Volume	3.65	Prev Close	0.37
Employees	4	LT Debt/Eq	0.00	Earnings	Jun 03	SMA200	-54.27%	Avg Volume	126.86K	Price	0.35
IPO	Sep 16, 2024	Option/Short	No / Yes	EPS/Sales Surpr.	0.00% -	Trades		Volume	462,586	Change	-6.62%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)